Clinical Trial Update: Glucagon Modulation of Ghrelin Secretion [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating glucagon modulation of ghrelin secretion. The conditions studied include obesity and diabetes mellitus type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Healthy Subjects, Obesity | Phase 3 | Status: UNKNOWN